Industry benchmarking report on publicly traded CBD companies
Industry benchmarking report on publicly traded CBD companies The passage provides market sizing and retail footprint data for cannabis‑derived companies but contains no specific allegations, financial flows, or links to high‑level officials. It offers limited investigative value beyond general industry context. Key insights: Lists CEOs and executives of several CBD firms (e.g., Brian Athaide of TGOD, James Hamilton of NEPT).; Notes an agreement between Organigram and 1812 Hemp for hemp research.; Provides retail store counts and revenue figures for major CBD brands.
Summary
Industry benchmarking report on publicly traded CBD companies The passage provides market sizing and retail footprint data for cannabis‑derived companies but contains no specific allegations, financial flows, or links to high‑level officials. It offers limited investigative value beyond general industry context. Key insights: Lists CEOs and executives of several CBD firms (e.g., Brian Athaide of TGOD, James Hamilton of NEPT).; Notes an agreement between Organigram and 1812 Hemp for hemp research.; Provides retail store counts and revenue figures for major CBD brands.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.